Lantern Pharma

Lantern Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lantern Pharma (LTRN) as of Oct 27, 2026 is -17.98 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -22.22 M USD — a change of -19.08% (higher).

EBITDA

-17.98 MUSD

YoY

-19.08%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lantern Pharma is 2025 -17.98 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lantern Pharma was 2024 -22.22 M USD. It decreases by -19.08% higher compared to the previous year.

The Lantern Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-1.73 M USD
Jan 1, 2019
-2.43 M USD
Jan 1, 2020
-5.91 M USD
Jan 1, 2021
-12.59 M USD
Jan 1, 2022
-14.43 B USD
Jan 1, 2023
-17.88 M USD
Jan 1, 2024
-22.22 M USD
Jan 1, 2025
-17.98 M USD
The Lantern Pharma EBITDA history
YEAREBITDAYoY
-17.98 MUSD-19.08%
-22.22 MUSD+24.27%
-17.88 MUSD-99.88%
-14.43 BUSD+114,522.91%
-12.59 MUSD+113.12%
-5.91 MUSD+143.32%
-2.43 MUSD+40.65%
-1.73 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Lantern Pharma Stock analysis

What does Lantern Pharma do? Lantern Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lantern Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lantern Pharma is -17.98 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Lantern Pharma changed from -22.22 M USD to -17.98 M USD, representing a -19.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Lantern Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Lantern Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Lantern Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Lantern Pharma